Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BIVI

BioVie Inc

May 22 • 04:00PM ET

1.52

+0.04 2.70 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: ANVS ALZN TNXP DMAC INMB

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.27	Insider Own	4.75%	Shs Outstand	7.54M	Perf Week	16.03%
Market Cap	11.46M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.18M	Perf Month	6.29%
Enterprise Value	-1.34M	PEG	-	EPS next Q	-	Inst Own	13.80%	Short Float	2.47%	Perf Quarter	21.60%
Income	-19.96M	P/S	-	EPS this Y	-	Inst Trans	-1.74%	Short Ratio	2.25	Perf Half Y	10.95%
Sales	0.00M	P/B	0.73	EPS next Y	-	ROA	-94.45%	Short Interest	0.18M	Perf YTD	31.03%
Book/sh	2.07	P/C	0.87	EPS next 5Y	-	ROE	-106.43%	52W High	12.10 -87.44%	Perf Year	-85.24%
Cash/sh	1.74	P/FCF	-	EPS past 3/5Y	51.42% 55.38%	ROIC	-125.89%	52W Low	1.06 43.40%	Perf 3Y	-99.77%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.63% 7.85%	Perf 5Y	-99.90%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	79.70%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-99.93%
Dividend Ex-Date	-	Quick Ratio	9.97	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.97	EPS Q/Q	53.63%	SMA20	1.98%	Beta	0.70	Target Price	12.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	4.89%	Rel Volume	0.80	Prev Close	1.48
Employees	13	LT Debt/Eq	0.01	Earnings	Dec 03	SMA200	0.31%	Avg Volume	78.86K	Price	1.52
IPO	May 05, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	63,094	Change	2.70%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)